Found: 9
Select item for more details and to access through your institution.
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).
- Published in:
- 2011
- By:
- Publication type:
- journal article
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 586, doi. 10.1002/cncr.27760
- By:
- Publication type:
- Article
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).
- Published in:
- 2008
- By:
- Publication type:
- journal article
Efficacy of Lamotrigine in the Management of Chemotherapy-induced Peripheral Neuropathy.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 12, p. 2802, doi. 10.1002/cncr.23482
- By:
- Publication type:
- Article
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.
- Published in:
- 1993
- By:
- Publication type:
- journal article
A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 1, p. 39, doi. 10.1007/s00280-004-0969-9
- By:
- Publication type:
- Article
Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
- Published in:
- 2017
- By:
- Publication type:
- journal article